Hypertrophic Cardiomyopathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients are selected with a certain diagnostic standard of HCM. 2. All enrolled patients underwent standardized cardiovascular MRI. 3. All enrolled patients are willing to provide peripheral blood for whole exon sequencing or have completed whole exon sequencing. 4. Informed consent is obtained from all participants.
Exclusion criteria
Exclusion criteria: 1. Patients who do not meet the diagnostic standard, including secondary left ventricular hypertrophy are excluded. 2. Patients with age less than 18 years old are excluded. 3. Patients with poor CMR image quality and CMR contraindications are excluded 4. Patients are unwilling to participate in the study or do not sign the informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sudden cardiac death;Sudden cardiac death; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sudden cardiac death;Sudden cardiac death;Sudden cardiac death;Sudden cardiac death;Sudden cardiac death; | — |
Countries
China
Contacts
West China Hospital, Sichuan University